LOS ANGELES, United States, via ETELIGIS INC., 11/09/2012 - - Digital Generation Inc(NASDAQ: DGIT) shares gained 11.91% to $9.49. Alex Meruelo issued a statement regarding Digital Generation. He said that he is Digital Generation's largest shareholder. Meruelo Investment Partners LLC and he are committed to the Company's success and maximizing value for all shareholders, including through the consummation (via the Company's existing strategic alternatives process or otherwise) of a timely sale of the Company or any other strategic alternative that is in the best interests of shareholders.
Will DGIT Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=DGIT
Doral Financial Corp.(NYSE: DRL) shares increased 2.73% to $0.750 in the morning hour. The company reported net loss of $32.5 million for the quarter ended September 30, 2012, compared to a net loss of $1.6 million for the quarter ended June 30, 2012 and a net loss of $30.2 million for the quarter ended September 30, 2011. For the nine months ended September 30, 2012, Doral reported a net loss of $31.6 million compared to a net loss of $22.4 million for the same period of 2011.
How Should Investors Trade DRL After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=DRL
Sequenom, Inc.(NASDAQ: SQNM) stock jumped 18.81% to $3.60 after the company reported revenue of $22.9 million for the third quarter of 2012, an increase of 25% from revenue of $18.3 million in the second quarter of 2012 and a 68% increase compared to revenue of $13.6 million for the third quarter of 2011.
Get Free Special Trend Analysis On SQNM Here http://beststocksdaily.com/p2/index.php?company=SQNM
ISIS Pharmaceuticals, Inc.(NASDAQ: ISIS) stock surged 15.51% to $8.86 after the company reported a pro forma net operating loss (NOL) of $26.0 million and $36.0 million for the three and nine months ended September 30, 2012, respectively, compared to a pro forma NOL of $20.0 million and $44.9 million for the same periods in 2011. The Company ended the third quarter of 2012 with $343.6 million in cash.
Additionally, ISIS and GlaxoSmithKline, or GSK, have announced the development plan to initiate a Phase II/III clinical study with ISIS-TTRRx.
Moreover,Cowen upgraded shares of ISIS from a neutral rating to an outperform rating in a research report released today.
Get Free Special Trend Analysis On ISIS Here http://beststocksdaily.com/p2/index.php?company=ISIS
Amarin Corporation plc (ADR)(NASDAQ: AMRN) stock climbed 6.74% to $10.95 after the company reported a third-quarter GAAP net loss of $26.4 million, or $0.18 per share, as compared to net income of $96.3 million, or $0.62 per share in the year ago quarter. Analysts expected the company to report a loss of $0.22 per share for the quarter. Adjusted non-GAAP adjusted net loss was $39.4 million or $0.26 per share, compared to a non-GAAP adjusted net loss of $11.0 million or $0.08 per share for the same period in the prior year.
Get Free Special Trend Analysis On AMRN Here http://beststocksdaily.com/p2/index.php?company=AMRN
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA